Bioavailability Study of XS003 (Nilotinib)
Clinical trial NCT07138352 · COMPLETED
Trial details
- NCT number
- NCT07138352
- Sponsor
- Xspray Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-03
- Primary completion
- 2025-01-08
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.